Angelici E - Search Results

1

Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia.

Angelici E, Contini C, Sebastiani G, Folgori F, Delia S, Serra P, Magno MS. Angelici E, et al. J Med Microbiol. 1996 Aug;45(2):149-52. doi: 10.1099/00222615-45-2-149. J Med Microbiol. 1996. PMID: 8683552

2

Alveolar cell population in HIV infected patients.

Palange P, Carlone S, Venditti M, Antony VB, Angelici E, Forte S, Sorice F, Serra P. Palange P, et al. Among authors: angelici e. Eur Respir J. 1991 Jun;4(6):639-42. Eur Respir J. 1991. PMID: 1889489

3

Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients.

Angelici E, Contini C, Romani R, Epifano O, Serra P, Canipari R. Angelici E, et al. AIDS. 1996 Mar;10(3):283-90. doi: 10.1097/00002030-199603000-00007. AIDS. 1996. PMID: 8882668 Clinical Trial.

4

Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.

Angelici E, Contini C, Spezzano M, Romani R, Carfagna P, Serra P, Canipari R. Angelici E, et al. J Eukaryot Microbiol. 1999 Sep-Oct;46(5):149S. J Eukaryot Microbiol. 1999. PMID: 10519296 No abstract available.

5

Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia.

Angelici E, Contini C, Spezzano M, Romani R, Carfagna P, Serra P, Canipari R. Angelici E, et al. Microbiol Immunol. 2001;45(8):605-11. doi: 10.1111/j.1348-0421.2001.tb01291.x. Microbiol Immunol. 2001. PMID: 11592634 Free article.

6

Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii.

Angelici E, Contini C, Carfagna P, Romani R, Magno MS, Serra P, Canipari R. Angelici E, et al. J Eukaryot Microbiol. 2001;Suppl:150S-151S. doi: 10.1111/j.1550-7408.2001.tb00494.x. J Eukaryot Microbiol. 2001. PMID: 11906036 No abstract available.

7

Structural changes in rat Pneumocystis carinii surface antigens after terbinafine administration in experimental P. carinii pneumonia.

Contini C, Angelici E, Canipari R. Contini C, et al. Among authors: angelici e. J Antimicrob Chemother. 1999 Feb;43(2):301-4. doi: 10.1093/jac/43.2.301. J Antimicrob Chemother. 1999. PMID: 11252340

8

Carriage of Pneumocystis carinii in children with chronic lung diseases.

Contini C, Romani R, Cultrera R, Angelici E, Villa MP, Ronchetti R. Contini C, et al. Among authors: angelici e. J Eukaryot Microbiol. 1997 Nov-Dec;44(6):15S. doi: 10.1111/j.1550-7408.1997.tb05743.x. J Eukaryot Microbiol. 1997. PMID: 9508407 No abstract available.

9

Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without P. Jiroveci infection.

Angelici E, Spezzano M, Vaccari S, Valentini SB, Romani R, Contini C, Canipari R. Angelici E, et al. Microb Pathog. 2006 Jul;41(1):1-9. doi: 10.1016/j.micpath.2006.03.003. Epub 2006 May 15. Microb Pathog. 2006. PMID: 16704917

10

Effects of fenoterol on oxygen transport in patients with chronic airflow obstruction.

Carlone S, Angelici E, Palange P, Serra P, Farber MO. Carlone S, et al. Among authors: angelici e. Chest. 1988 Apr;93(4):790-4. doi: 10.1378/chest.93.4.790. Chest. 1988. PMID: 3349836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters